Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Antoni Ribas

Improved Overall Survival in Melanoma With Combined Dabrafenib and Trametinib

New England Journal of Medicine
Medicine
2015English

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

New England Journal of Medicine
Medicine
2013English

Tumor Immunotherapy Directed at PD-1

New England Journal of Medicine
Medicine
2012English

A Clinical Microchip for Evaluation of Single Immune Cells Reveals High Functional Heterogeneity in Phenotypically Similar T Cells

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Tumour Micro-Environment Elicits Innate Resistance to RAF Inhibitors Through HGF Secretion

Nature
Multidisciplinary
2012English

Combining Targeted Therapy With Immunotherapy inBRAF-Mutant Melanoma: Promise and Challenges

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-Treated Patients With BRAFV600-mutated Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Single-Cell Analysis Resolves the Cell State Transition and Signaling Dynamics Associated With Melanoma Drug-Induced Resistance

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy